European Commissioner Joaquin Almunia moved to end the patent wars between smartphone rivals Apple and Motorola Mobility, announcing Tuesday that Motorola was wrong to launch litigation against Apple for allegations of patent infringement.
According to reports, the Commission told the companies to halt their lawsuits against each other in hopes its decision will help curb other companies’ suits as well.
”The so-called smartphone patent wars should not occur at the expense of consumers,” Almunia said in a statement.
As previously reported from unnamed sources, Motorola will not be issued a fine in the Commission’s ruling. But the regulator did reprimand the company for filing a lawsuit against Apple in Germany on allegations Apple infringed on a standard-essential patent.
The Commission also told Samsung to stop filing similar lawsuits as long as their rivals sign patent licensing agreements.
US patent wars
In the US, the patent wars rage on, however, as Apple and Samsung delivered their closing arguments Tuesday before jurors deliberate to decide whether Samsung infringed on Apple smartphone patents.
Samsung similarly claims Apple infringed on its patents and is reportedly seeking an import ban on the iPhone 5.
Apple, on the other hand, is seeking billions of dollars in damages from Samsung which, in its defense, argues that Apple exaggerated the importance of those technologies on which Apple says Samsung infringed.
The two companies have been going back and forth in their patent arguments for three years across the world, reports say.
Full content: Reuters and Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas